NY Times

SEPTEMBER 21, 2021

The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.

Specialty Pharmacies 90

Specialty Pharmacies Labelling Packaging 90

Proxsys Rx

MAY 3, 2023

340B ESP and drug manufacturer restrictions are only part of the reason As we noted in a previous post , for 340B-eligible hospitals dealing with increasingly squeezed bottom lines, an in-house specialty pharmacy offers enormous savings and revenue potential. Hospitals can operate specialty pharmacies alongside their retail pharmacies.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Documentation Labelling 52

Drug Channels

MARCH 4, 2025

Emerging controversies, challenges, and threats to watch in the industry And much more!

Specialty Pharmacies 94

Specialty Pharmacies Drug Pricing Labelling 94

Proxsys Rx

DECEMBER 11, 2023

Nowhere have those restrictions been more punitive — and, often, unwarranted — than with specialty pharmacy medications; drugs which typically represent the most expensive (and profitable) in manufacturers’ product lines. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Labelling 52

Proxsys Rx

MARCH 1, 2024

Nowhere have those restrictions been more punitive — and, often, unwarranted — than with specialty pharmacy medications; drugs which typically represent the most expensive (and profitable) in manufacturers’ product lines. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.

Specialty Pharmacies 40

Specialty Pharmacies Hospitals Drug Pricing Labelling 40

pharmaphorum

SEPTEMBER 30, 2022

An open-label extension revealed that ALS patients had around six more months before being hospitalised, requiring a ventilator or dying compared to the control group and, according to Amylyx, patients who continued taking the drug survived about 10 months longer. .

Specialty Pharmacies 98

Specialty Pharmacies Labelling Hospitals Drug Development 98

National Association of Boards of Pharmacy

MARCH 22, 2024

The labeled indications for methotrexate later expanded to include the treatment of non-oncologic conditions, including psoriasis and rheumatoid arthritis. The community pharmacy dispensed a three-month quantity of medication but provided instructions on the label to take 15 mg (six 2.5 mg tablets) once daily.

Community Pharmacies 52

Community Pharmacies Specialty Pharmacies Patient Counseling Labelling 52